ProShare Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-13,570
| Closed | -$264K | – | 1832 |
|
|
2018
Q1 | $264K | Sell |
13,570
-1,581
| -10% | -$31K | ﹤0.01% | 1395 |
|
|
2017
Q4 | $252K | Sell |
15,151
-34,970
| -70% | -$641K | ﹤0.01% | 1513 |
|
|
2017
Q3 | $1.02M | Buy |
50,121
+3,162
| +7% | +$60.4K | 0.01% | 725 |
|
|
2017
Q2 | $756K | Sell |
46,959
-4,187
| -8% | -$61.9K | 0.01% | 820 |
|
|
2017
Q1 | $647K | Sell |
51,146
-12,128
| -19% | -$146K | 0.01% | 913 |
|
|
2016
Q4 | $838K | Buy |
63,274
+5,967
| +10% | +$102K | 0.01% | 855 |
|
|
2016
Q3 | $1.36M | Sell |
57,307
-10,451
| -15% | -$281K | 0.02% | 599 |
|
|
2016
Q2 | $1.95M | Buy |
67,758
+2,197
| +3% | +$71.6K | 0.03% | 525 |
|
|
2016
Q1 | $2.1M | Sell |
65,561
-5,711
| -8% | -$201K | 0.03% | 440 |
|
|
2015
Q4 | $3.05M | Buy |
71,272
+5,531
| +8% | +$221K | 0.04% | 389 |
|
|
2015
Q3 | $2.31M | Sell |
65,741
-5,442
| -8% | -$245K | 0.03% | 441 |
|
|
2015
Q2 | $3.27M | Sell |
71,183
-5,048
| -7% | -$240K | 0.05% | 366 |
|
|
2015
Q1 | $3.57M | Buy |
76,231
+9,149
| +14% | +$364K | 0.04% | 393 |
|
|
2014
Q4 | $2.13M | Sell |
67,082
-702
| -1% | -$20.5K | 0.02% | 545 |
|
|
2014
Q3 | $1.61M | Sell |
67,784
-13,673
| -17% | -$350K | 0.02% | 851 |
|
|
2014
Q2 | $2.44M | Sell |
81,457
-44,941
| -36% | -$1.21M | 0.03% | 628 |
|
|
2014
Q1 | $3.34M | Buy |
126,398
+87,907
| +228% | +$2.2M | 0.04% | 441 |
|
|
2013
Q4 | $968K | Sell |
38,491
-32,256
| -46% | -$720K | 0.01% | 987 |
|
|
2013
Q3 | $1.45M | Buy |
70,747
+9,974
| +16% | +$206K | 0.03% | 599 |
|
|
2013
Q2 | $1.21M | Buy |
+60,773
| New | +$1.08M | 0.02% | 730 |
|
ProShare Advisors's IPXL Position: Q2 2018 in Review
ProShare Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 13,570 shares — an estimated $264K sold.
ProShare Advisors first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $3.57M in Q1 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- ProShare Advisors reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- ProShare Advisors sold 13,570 Impax Laboratories, Inc. shares in Q2 2018, an estimated $264K.
- ProShare Advisors first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- ProShare Advisors's Impax Laboratories, Inc. position peaked at $3.57M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on ProShare Advisors's 13F filing for Q2 2018, filed 13 Aug 2018.